Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes
Clinical trial NCT01026194 · COMPLETED
Trial details
- NCT number
- NCT01026194
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-06-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.